SGLT2 Inhibitor Ipragliflozin Alone and Combined With Pioglitazone Prevents Progression of Nonalcoholic Steatohepatitis in a Type 2 Diabetes Rodent Model
Physiological Reports - United States
doi 10.14814/phy2.14286
Full Text
Open PDFAbstract
Available in full text
Categories
Date
November 1, 2019
Authors
Publisher
Wiley